The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
Euro-Med Laboratories Phil., Inc.EURO
PSE Disclosure Form 17-18 - Other SEC Forms/Reports/Requirements
| Form/Report Type |
Certification on Corporate Governance Training |
| Report Period/Report Date |
Dec 19, 2024 |
| Description of the Disclosure |
Pursuant to SEC Memorandum Circular No. 20, Series of 2013, we are submitting herewith the Certificates of Participation for having attended the webinar “The Next Level in ESG & Sustainability : Going Beyond Compliance and Reporting” conducted by the Center for Global Best Practices Foundation, Inc. held last 06 December 2024 attended by the following Directors and Officers of the Corporation. The Certificates were received today and were informed that these were already submitted by the Center of Global Best Practices thru SEC e-FAST.
• Mr. Edwin D. Feist – Vice Chairman of the Board/Independent Director
• Esperanza I. Cabral, M.D. – Independent Director
• Evangeline V. Baviera, M.D. – Director/Executive Vice President
• Mrs. Janice R. Ong – Corporate Secretary & Investment Relations Officer
For your information and reference, attached are copies of their Certificate of Attendance.
Thank you very much. |
Filed on behalf by:
| Name |
Janice Ong |
| Designation |
Corporate Secretary |